These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
644 related articles for article (PubMed ID: 32804027)
1. TGF-β is associated with poor prognosis and promotes osteosarcoma progression Ma K; Zhang C; Li W Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027 [TBL] [Abstract][Full Text] [Related]
2. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling. Zhang Y; Cheng H; Li W; Wu H; Yang Y Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524 [TBL] [Abstract][Full Text] [Related]
3. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. Zheng J; Liu C; Shi J; Wen K; Wang X Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077 [TBL] [Abstract][Full Text] [Related]
4. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway. Ma K; Zhang C; Li W Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222 [TBL] [Abstract][Full Text] [Related]
5. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells. Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway. Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636 [TBL] [Abstract][Full Text] [Related]
7. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Sun H; Yin M; Qian W; Yin H Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951 [TBL] [Abstract][Full Text] [Related]
8. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways. Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Shang Y; Wang LQ; Guo QY; Shi TL Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752 [TBL] [Abstract][Full Text] [Related]
10. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway. He P; Wang Z; Sheng B; Xu Y; Feng S; Huang Y; Gong F; Tang L; Xie L Histol Histopathol; 2020 Dec; 35(12):1511-1520. PubMed ID: 33372687 [TBL] [Abstract][Full Text] [Related]
11. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway. Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway. Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593 [TBL] [Abstract][Full Text] [Related]
13. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway. Han Y; Zhao X; Sun Y; Sui Y; Liu J J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098 [TBL] [Abstract][Full Text] [Related]
14. Upregulation and biological function of transmembrane protein 119 in osteosarcoma. Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199 [TBL] [Abstract][Full Text] [Related]
15. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway. Wei Z; Xia K; Zheng D; Gong C; Guo W Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway. Hou CH; Lin FL; Tong KB; Hou SM; Liu JF Biochem Pharmacol; 2014 Jun; 89(4):453-63. PubMed ID: 24685520 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling. Yu B; Jiang K; Zhang J Mol Med Rep; 2018 May; 17(5):6736-6744. PubMed ID: 29488603 [TBL] [Abstract][Full Text] [Related]
18. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727 [TBL] [Abstract][Full Text] [Related]
19. Targeted PLK1 suppression through RNA interference mediated by high-fidelity Cas13d mitigates osteosarcoma progression via TGF-β/Smad3 signalling. Yuan Y; Cao D; Zhang A; Liu Z; Deng Z; Zhang S J Cell Mol Med; 2024 May; 28(10):e18400. PubMed ID: 38780513 [TBL] [Abstract][Full Text] [Related]
20. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway. Song R; Tian K; Wang W; Wang L Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]